Fcγ receptor IIIA genotype is associated with rituximab response in antimyelin-associated glycoprotein neuropathy

Abraham C J Stork; Nicolette C Notermans; Leonard H van den Berg; Raymond D Schellevis; Jikke-Mien F Niermeijer; Maaike Nederend; Jeanette H W Leusen; W-Ludo van der Pol

doi:10.1136/jnnp-2013-306958

Article info

Neuromuscular

Short report

Fcγ receptor IIIA genotype is associated with rituximab response in antimyelin-associated glycoprotein neuropathy

Authors

Abraham C J Stork Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands PubMed articles Google scholar articles
Nicolette C Notermans Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands PubMed articles Google scholar articles
Leonard H van den Berg Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands PubMed articles Google scholar articles
Raymond D Schellevis Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands PubMed articles Google scholar articles
Jikke-Mien F Niermeijer Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands PubMed articles Google scholar articles
Maaike Nederend Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands PubMed articles Google scholar articles
Jeanette H W Leusen Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands PubMed articles Google scholar articles
W-Ludo van der Pol Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands PubMed articles Google scholar articles

Correspondence to W-Ludo van der Pol, Department of Neurology, HP F02.226, Brain Center Rudolf Magnus, UMC Utrecht, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands; wpol2{at}umcutrecht.nl

View Full Text

Citation

Stork ACJ, Notermans NC, van den Berg LH, et al

Fcγ receptor IIIA genotype is associated with rituximab response in antimyelin-associated glycoprotein neuropathy

Journal of Neurology, Neurosurgery & Psychiatry 2014;85:918-920.

Publication history

Received October 7, 2013
Revised January 5, 2014
Accepted January 8, 2014
First published January 31, 2014.

Online issue publication

April 13, 2016

Article Versions

Previous version (13 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password